OneMedNet (NASDAQ:ONMD) Director Acquires $750,001.24 in Stock

OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) Director Thomas Kosasa acquired 129,758 shares of the business’s stock in a transaction that occurred on Wednesday, October 7th. The stock was bought at an average cost of $5.78 per share, for a total transaction of $750,001.24. Following the completion of the purchase, the director owned 1,983,573 shares of the company’s stock, valued at $11,465,051.94. This trade represents a 7.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Thomas Kosasa also recently made the following trade(s):

  • On Thursday, July 30th, Thomas Kosasa bought 144,927 shares of OneMedNet stock. The stock was bought at an average price of $6.90 per share, for a total transaction of $999,996.30.

OneMedNet Price Performance

NASDAQ:ONMD opened at $4.75 on Friday. The company has a 50 day simple moving average of $6.03 and a two-hundred day simple moving average of $7.19. OneMedNet Corporation has a fifty-two week low of $3.61 and a fifty-two week high of $28.20.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 24th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

View Our Latest Report on ONMD

About OneMedNet

(Get Free Report)

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.

Featured Stories

Insider Buying and Selling by Quarter for OneMedNet (NASDAQ:ONMD)

Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.